{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:29:07Z","timestamp":1762658947768},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s11892-006-0004-0","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T05:11:33Z","timestamp":1180069893000},"page":"344-349","source":"Crossref","is-referenced-by-count":6,"title":["Pramlintide: A new tool in diabetes management"],"prefix":"10.1007","volume":"6","author":[{"given":"Laura L.","family":"Want","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/oby.2002.147","volume":"10","author":"TK Reda","year":"2002","unstructured":"Reda TK, Geliebter A, Pi-Sunyer FX: Amylin, food intake, and obesity. Obes Res 2002, 10:1087\u20131091.","journal-title":"Obes Res"},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/diaclin.20.3.137","volume":"20","author":"JB Buse","year":"2002","unstructured":"Buse JB, Weyer C, Maggs DG: Amylin replacement with pramlintide in type 1 and type 2 diabetes: a physiological approach to overcome barriers with insulin therapy. Clin Diabetes 2002, 20:137\u2013144.","journal-title":"Clin Diabetes"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diacare.28.3.632","volume":"28","author":"A Ceriello","year":"2005","unstructured":"Ceriello A, Piconi L, Quagliaro L, et al.: Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes. Diabetes Care 2005, 28:632\u2013637. Describes the effect of pramlintide in reducing postprandial glycemic excursions and oxidative stress markers, which have been implicated in increased micro-and macrovascular complication risk.","journal-title":"Diabetes Care"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.26.1.1","volume":"26","author":"C Levetan","year":"2003","unstructured":"Levetan C, Want LL, Weyer C, et al.: Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care 2003, 26:1\u20138.","journal-title":"Diabetes Care"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2337\/diacare.24.2.371","volume":"24","author":"CK Rayner","year":"2001","unstructured":"Rayner CK, Samson M, Jones K, Horowitz M: Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001, 24:371\u2013381.","journal-title":"Diabetes Care"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0016-5085(97)70080-5","volume":"113","author":"E Schvarcz","year":"1997","unstructured":"Schvarcz E, Palmer M, Aman J, et al.: Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 1997, 113:60\u201366.","journal-title":"Gastroenterology"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1463-1326.2004.00417.x","volume":"7","author":"SA Amiel","year":"2005","unstructured":"Amiel SA, Heller SR, Macdonald IA, et al.: The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes. Diabetes Obes Metab 2005, 7:504\u2013516.","journal-title":"Diabetes Obes Metab"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1464-5491.2004.01319.x","volume":"21","author":"RE Ratner","year":"2004","unstructured":"Ratner RE, Dickey R, Fineman M, et al.: Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in type 1 diabetes mellitus: a 1-year, randomized controlled trial. Diabet Med 2004, 21:1204\u20131212. Presents pivotal type 1 diabetes study data.","journal-title":"Diabet Med"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diacare.25.4.724","volume":"25","author":"F Whitehouse","year":"2002","unstructured":"Whitehouse F, Kruger DF, Fineman M, et al.: A randomized study and open-label extension evaluating the long-term ef.cacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes. Diabetes Care 2002, 25:724\u2013730.","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"4_CR10","first-page":"62","volume":"52","author":"O Kolterman","year":"2003","unstructured":"Kolterman O, Burrell T, Shen L, et al.: Initiation of pramlintide using dose-titration in intensively-treated patients with type 1 diabetes resulted in mitigation of nausea and hypoglycemia [abstract]. Diabetes 2003, 52(suppl 2):62-LB.","journal-title":"Diabetes"},{"key":"4_CR11","unstructured":"Symlin (pramlintide acetate) Injection. http:\/\/www.symlin. com\/pdf\/SYMLIN-pi-combined.pdf. Accessed April 25, 2006."},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","volume":"26","author":"PA Hollander","year":"2003","unstructured":"Hollander PA, Levy P, Fineman MS, et al.: Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care 2003, 26:784\u2013790. Presents pivotal type 2 diabetes study data.","journal-title":"Diabetes Care"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/15209150252924094","volume":"4","author":"RE Ratner","year":"2002","unstructured":"Ratner RE, Want LL, Fineman MS, et al.: Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes. Diabetes Technol Ther 2002, 4:51\u201361.","journal-title":"Diabetes Technol Ther"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/dmrr.419","volume":"20","author":"DG Maggs","year":"2004","unstructured":"Maggs DG, Fineman M, Kornstein J, et al.: Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study. Diabetes Metab Res Rev 2004, 20:55\u201360.","journal-title":"Diabetes Metab Res Rev"},{"issue":"suppl 1","key":"4_CR15","first-page":"A12","volume":"55","author":"DM Karl","year":"2005","unstructured":"Karl DM, Wang Y, Lorenzi G, Freeman J S: In an openlabel clinical study pramlintide lowered A1C, body weight, and insulin use in patients with type 2 diabetes failing to achieve glycemic targets with insulin therapy. Diabetes 2005, 55(suppl 1):A12.","journal-title":"Diabetes"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","volume":"48","author":"I Chapman","year":"2005","unstructured":"Chapman I, Parker B, Doran S, et al.: Effect of pramlintide on satiety and food intake in obese subjects with type 2 diabetes. Diabetologia 2005, 48:838\u2013848.","journal-title":"Diabetologia"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00011","volume":"124","author":"R Turner","year":"1996","unstructured":"Turner R, Cull C, Holman R: United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996, 124:136\u2013145.","journal-title":"Ann Intern Med"},{"key":"4_CR18","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes 16: overview of 6 years\u2019 therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group [no authors listed]. Diabetes 1995, 44:1249\u20131258.","DOI":"10.2337\/diab.44.11.1249"},{"issue":"suppl 2","key":"4_CR19","first-page":"A44","volume":"47","author":"LL Want","year":"2004","unstructured":"Want LL, Ratner RE, Uwaifo GI: Safety and tolerability of long-term pramlintide therapy. Diabetologia 2004, 47(suppl 2):A44.","journal-title":"Diabetologia"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajhp\/62.8.816","volume":"62","author":"C Weyer","year":"2005","unstructured":"Weyer C, Fineman MS, Strobel S, et al.: Properties of pramlintide and insulin upon mixing. Am J Health Syst Pharm 2005, 62:816\u2013822.","journal-title":"Am J Health Syst Pharm"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-006-0004-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-006-0004-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-006-0004-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:14Z","timestamp":1559433374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-006-0004-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s11892-006-0004-0","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}